VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vector1 who wrote (4198)	2/26/1998 3:53:00 PM
From: James Silverman	Read Replies (2) of 9719

Took a few minutes to look up dry powder inhalers. Here's a list of a few competitors. Delsys/Glaxo Amherst Process Instrument ACTIF/Norton Healthcare-MDPI-late stage clinicals Hovione-Flowcaps Fisons-Rotohaler DPI-on the market With a big sales force, DURA should be able to penetrate the market successfully. However, I'd still call it a fancy generic since albuterol in DPI's are already out there. So maybe I'd call it a super generic or a nice me-too product. KOSP is working on an MDI version. Rick: Up yours, you sarCISTic pRick.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next